论文部分内容阅读
本刊讯浙江钱江生物化学股份有限公司(以下简称钱江生化)近日发布了2016年度年中报告。2016年上半年,该公司实现营业收入2.24亿元,同比增长7.77%。归属于上市公司股东的净利润为2389.01万元,同比增长100.61%。归属于上市公司股东的扣除非经常性损益的净利润为1827.68万元,同比增长140.45%。钱江生化表示净利润的增长主要系该公司主营业务
Our correspondent Zhejiang Qianjiang Biochemical Co., Ltd. (hereinafter referred to Qianjiang biochemical) recently released 2016 annual report. The first half of 2016, the company achieved operating income of 224 million yuan, an increase of 7.77%. Net profit attributable to shareholders of listed companies was 23,890,100 yuan, an increase of 100.61% over the same period of last year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was RMB18.2768 million, an increase of 140.45% over the same period of last year. Qianjiang Biochemical said the growth of net profit mainly due to the company’s main business